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Abstract
Determining the complete set of ligands’ binding/unbinding pathways is important
for drug discovery and to rationally interpret mutation data. Here we have developed a
metadynamics-based technique that addressed this issue and allows estimating affinities
in the presence of multiple escape pathways. Our approach is shown on a Lysozyme T4
variant in complex with the benzene molecule. The calculated binding free energy is in
agreement with experimental data. Remarkably, not only we were able to find all the
previously identified ligand binding pathways, but also we uncovered 3 new ones. This
results were obtained at a small computational cost, making this approach valuable for
practical applications, such as screening of small compounds libraries.
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Describing mechanisms and energetics of ligand binding and unbinding from their tar-
gets is of great importance in drug design. The prediction of poses, affinities, and binding
kinetics helps in understanding the effect of chemical decorations on the ligand and/or in
mutations in the host system.1 These important problems are most often associated with
rare events and they can be adequately studied only with enhanced sampling (ES) methods,
that allow estimating the free energy as a function of appropriate collective variables (CVs).
In this context, we have recently used one of such methods (funnel2 well-tempered meta-
dynamics3,4), combined with novel and powerful dimension reduction approach to identify
the CVs, to predict the free energy landscape of a ligand binding to a typical membrane
receptor, the muscarinic M2.
5 The picture that did emerge from our study was relatively
simple, with two rather diverse escape routes of the ligand towards the extracellular region.
However, proteins can exhibit a much larger flexibility with many more diverse escape path-
ways.6 This is the case of the well-studied lysozyme T4 L99A variant (hereafter T4L)7–9 (see
Figure 1) in complex with benzene. The protein fold consists of two domains: the N-terminal
one (residues 1-70) formed by 3 α-helices and 3 antiparallel β-strands, and a barrel-shaped
C-terminal domain (residues 71-162) formed by 8 α-helices, in which the ligand accommo-
dates. The protein features several binding/unbinding pathways, whose complete picture
is not yet clear; indeed, a variety of ES approaches, with different force fields and solvent
representations (see Table 2) have identified up to five pathways involving the C-terminal
domain shown in Figure 3 (See SI).
Clearly, a computationally inexpensive methodology which would permit as an exhaustive
as possible exploration of all the binding pathways, along with their energetics, would be
highly desirable for a theory point of view and for drug discovery applications.
Here, we introduce a new practical method for addressing this issue at a modest compu-
tational cost. We shall do this in the frame of Well-tempered Metadynamics (WT-MetaD).
As it is well known, WT-MetaD relies on the choice of an appropriate set of CVs. We take
advantage of the fact that T4L flexibility is limited and thus its center of mass can be defined
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Figure 1: Cartoon representation of the T4L protein. The C-terminal domain is depicted in
red color. The benzene ligand is respresented in dark grey licorice. The N-terminal domain,
not involved in the binding process, is in light grey. The helices of the C-terminal domain
from C to H are labeled following Rydzewski et al.10
.
once and for all. Centered around this position we consider a sphere of finite radius ρs, larger
than the radius of gyration of our protein. Within this volume we use as CVs the spherical
coordinates (ρ, θ, ϕ). A repulsive potential is added at the border of the sphere so as to limit
the volume in the solvated state that needs to be sampled, increasing the probability of a
subsequent recrossing event. The restraining potential is in the form
Us(ρ(t)) =

1
2
k (ρ(t)− ρs)2 if ρ(t) > ρs
0 otherwise
(1)
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where k has to be large enough to prevent the ligand escaping from the confining volume. In
equation (1) ρ(t) is the distance of the ligand from the center of mass of the target protein,
and ρs is the radius of the spherical restraint.
This approach is an extension of funnel metadynamics, where a funnel-shaped potential
limits the volume accessible to the ligand in the solvated space, considering a single port of
entry for the ligand. Here, we are instead able to observe any binding/unbinding pathway
accessible.
The application of such a restraining potential causes a change in the translational entropy
of the solvated states. With the same spirit of previous works,2,11 the correction to the
binding free energy due to this constraint can be estimated to be
∆G0b = −RT log
(
C0Kb
)
= ∆GMetaD −RT log
(
V 0
4
3
piρ3s − Vprot
)
(2)
where R is the gas constant, T is the system temperature, Kb is the binding constant,
C0 = 1660A˚
3
is the standard concentration, V 0 is its reciprocal, ∆GMetaD is the binding free
energy obtained by WT-MetaD, and Vprot is the volume of the protein inside the restraining
potential. The derivation of this correction can be found on the SI.
To build our model, we used an experimental X-ray structure of T4L /benzene complex
(PDB code: 1L847). Details on the system preparation, equilibration and run parameters
can be found in the SI. The simulation were performed with GROMACS 2018.3,12 patched
with Plumed 2.5.13
We performed 5 different 200-ns long WT-MetaD simulations, using different values of ρs.
After reaching convergence, the calculated free energy surface (FES) as a function of ρ, θ, ϕ
is projected (with a reweighting procedure14) on two more informative CVs. These are the
distance from the center of mass of the C-terminal domain ρ and a CV that measures whether
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the ligand is in contact with the host protein, measured by the coordination number CN
CN =
∑
i∈A
∑
j∈B
1−
(
rij
r0
)n
1−
(
rij
r0
)m (3)
where A is the set of non-hydrogen atoms of the ligand, B is the set of non-hydrogen atoms
of the protein, r0=4.5 A˚ ,is the threshold to define a formed contact, rij is the distance
between atoms i and j, and m = 6 and n = 12 are the exponents of the switching function.
The projected FES (Figure 2) is shown as a function of different ρs in order to study the
influence of this parameter on the results. It is evident that, especially for shorter values of
Figure 2: Free energy surfaces in function of the restraint radius ρs.
ρs, the presence of the restraining potential induces some artificial minima at the border of
the ligand accessible volume. However, these artifacts decrease with increasing the ρs value
5
and in our case the estimate of ∆G0b does not change in a sensible way with ρs, appearing
to be consistent with the experimental data (see Table 1).
Table 1: Absolute free energy differences obtained with our technique at different radii of
the restraining sphere compared with experimental data.
ρs [A˚] ∆GMetaD [kcal/mol] T∆S [kcal/mol] ∆G
0
b [kcal/mol]
20 −3.6± 0.5 1.6 −5.2± 0.5
22 −3.2± 0.4 1.8 −5.0± 0.4
24 −3.8± 0.4 2.0 −5.8± 0.4
26 −3.4± 0.5 2.2 −5.6± 0.5
28 −3.1± 0.4 2.3 −5.4± 0.4
Experimental15 – – −5.2± 0.2
Having validated our approach, we turn our attention to the pathways emerging from
the WT-MetaD calculations. These are extracted by visual inspection of the trajectories.
We identified eight different pathways (A-H in Figure 3). Of those eight, five (A-E) have
already been reported in the literature10,16 (see Table 2).
Table 2: Comparison of the different techniques with respective results on the number of
identified pathways.
Source CV-based Force Field Water # Pathways
Miao et al.17 No Amber99SB explicit 1
Wang et al.18 Yes CHARMM22* explicit 1
Nunes-Alves et al.16 No CHARMM36 implicit 4
Rydzewski et al.10 Yes OPLS-AA/L explicit 5
This work Yes Amber14SB explicit 8
We discuss here only the new found ones (for a full description of all the 8 pathways, see
the SI). In pathway F the ligand moves toward the helices H, I, and J (see Figure 1). In
contrast with pathway C, that shares this first phase, during the solvation the ligand does
not interact with the helices G and H, and passes through the helices F and I. Pathway G
involve the passage of the ligand between the 3 helices H, I and , slightly broadening the dis-
tance between helices H and J. In contrast to all the others, H is the only one-way pathway
(see Figure 4): the ligand can enter between the helices E and H, but it cannot pursue the
same route for the unbinding transition because from the binding pose VAL149 and MET102
6
Figure 3: Bound state and binding pathways (A to H) of benzene to T4L C-terminal domain
(gray). The benzene ligand is colored from red to blue on passing from the bound to the
unbound state.
impede its motion toward helices H and E. Interestingly, the single-point mutation M102Q
has been studied previous in the literature to favor the binding of polar ligand inside T4L.9,19
Figure 4: Stacked histogram of the observed binding/unbinding transitions via different path-
ways. The data is coming from all the 5 metadynamics simulations with different ρs values
(see equation 2). The unbinding and binding processes are in red and blue, respectively.
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In conclusion, we presented a highly efficient approach to sample all the possible bind-
ing/unbinding pathways for a ligand inside a host protein. We shown that the choice of
the potential radius ρs does not influence the agreement with experimental data of our ∆G
0
b
estimation after the application of the entropic correction. Our approach was also able to
identify all the 5 previously found binding pathway, and to adding 3 new ones.
Our technique is totally general and does not need any information regarding the pathways
and the bound state.
All the data and PLUMED input files required to reproduce the results reported in this
paper are available on PLUMED-NEST (www.plumed-nest.org), the public repository of the
PLUMED consortium,20 as plumID:19.017.
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